Previous Article | Next Article 
Journal of Clinical Microbiology, December 1998, p. 3552-3557, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Genetic Variability among Group A and Group B
Respiratory Syncytial Viruses in a Children's Hospital
Wanicha Buraphacheep
Coggins,1,
Elliot J.
Lefkowitz,2 and
Wayne
M.
Sullender1,2,*
Departments of
Pediatrics1 and
Microbiology,2 University of Alabama at
Birmingham, Birmingham, Alabama
Received 28 May 1998/Returned for modification 13 August
1998/Accepted 31 August 1998
 |
ABSTRACT |
Respiratory syncytial (RS) viruses isolated over three epidemic
periods in a children's hospital in the United States were analyzed.
The viruses (n = 174) were characterized as to major antigenic group (group A or B) by a PCR-based assay. Group A RS viruses
were dominant the first 2 years, followed by a year with group B
dominance (ratios of group A to group B viruses for epidemic periods,
56/4 for 1993-1994, 42/3 for 1994-1995, and 19/50 for 1995-1996).
Genetic variability within the groups was assessed by restriction
fragment analysis of PCR products; 79 isolates were also analyzed by
nucleotide sequence determination of a variable region of the
glycoprotein G gene. Among the group A RS virus isolates, this
G-protein variable region had amino acid differences of as great as
38%. The G-protein amino acids of the group A viruses differed by up
to 31% from the G-protein amino acids of a prototype (A2) group A
virus. Among the group B RS virus G proteins, amino acid differences
were as great as 14%. The G-protein amino acids of the group B viruses
differed by up to 27% from the G-protein amino acids of a prototype
(18537) group B virus. The group A and group B RS viruses demonstrated
genetic variability between years and within individual years.
Phylogenetic analysis revealed that there were multiple evolutionary
lineages among both the group A and group B viruses. Among the recent
group B isolates, variability was less than that seen for the group A
viruses. However, comparisons to prototype strains revealed that the
group B RS viruses may vary more extensively than was observed over the
3 years studied in the present investigation.
 |
INTRODUCTION |
Respiratory syncytial (RS) virus is
the most common viral cause of lower respiratory tract infection in
infants and young children. Annual fall and winter epidemics occur in
temperate regions (10). Two major antigenic groups, groups A
and B, of RS virus were originally delineated by their reactivities
with monoclonal antibodies (MAbs) (3, 19). Genetic diversity
of the protein-G genes occurs within and between the two groups of RS
virus (16, 22).
Epidemiologic studies conducted in the United States with MAbs to
define the antigenic groups showed that there are three types of RS
virus epidemics: those in which group A or group B viruses were
dominant and those in which both groups circulate concurrently (2,
13, 14). Multiple lineages or strains of RS virus cocirculate
(2, 6). The analysis of group A clinical isolates from
successive epidemics in Birmingham, United Kingdom, showed that
different lineages predominated in each epidemic and that not all
lineages were present in every epidemic (7). Clinical
isolates of group A RS virus collected in Uruguay and Spain have been
analyzed. Viruses from separate phylogenetic branches were isolated
during the same epidemic period, and very similar viruses were isolated
in distant places and different years (12).
Several methods have been used to categorize RS virus clinical isolates
as to group and to assess variability within the groups. In addition to
antigenic characterization with MAbs, these methods include restriction
endonuclease analysis of small hydrophobic and nucleocapsid RS virus
protein genes (8), restriction endonuclease analysis of
G-protein gene cDNA (5, 24), RNase protection analysis
(11, 21), and nucleotide sequence analysis of the G-protein
gene (5, 23).
In this study, we analyzed RS viruses from the Children's Hospital of
Alabama from three consecutive epidemic periods (1993 to 1996). The
viruses were characterized as to group, and variability within the
groups was assessed by restriction fragment analysis of amplified cDNAs
and limited nucleotide sequencing of a variable region of the G-protein
gene. Both group A and group B viruses were studied. The data presented
here are the results of a molecular epidemiologic study of RS virus in
a children's hospital in the United States over three epidemic periods.
(This work was presented in part at the 35th Interscience Conference on
Antimicrobial Agents and Chemotherapy, San Francisco, Calif., 17 to 20 September 1995.)
 |
MATERIALS AND METHODS |
Cells and viruses.
Clinical samples were submitted to the
diagnostic virology laboratory of the Children's Hospital of Alabama
for respiratory viral cultures. Samples which grew RS virus were
recultivated in our laboratory, and a cell lysate was prepared for
reverse transcription-PCR (RT-PCR) as described previously
(24).
RT-PCR.
RNA was extracted from infected cell lysates by a
hot phenol extraction procedure. The extracted viral RNA was used as a
template for cDNA synthesis. RT-PCR was performed with primers F164,
G32, and G267 as described previously (24). Agarose gel
electrophoresis allowed a group designation to be made on the basis of
the size of the DNA fragment of the PCR product: 1.1 kb in length for
group B virus and 0.9 kb for group A virus. We repeated the RT-PCR for the group A viruses with primer G10 (GCAAACATGTCCAAAAACAAG;
complementary to bases 10 to 30 of the G-protein mRNA of the A2
virus) and F164 to yield a longer 1.1-kb group A DNA product.
Restriction endonuclease analysis.
The DNA fragments
obtained by PCR were analyzed for their genetic variability. Three
restriction endonuclease enzymes, PstI, RsaI, and
HincII, were used for the digestion of the group A PCR products. Group B virus PCR products were cut with AluI,
RsaI, and HincII enzymes. Digestion and analysis
of the resulting products were done as described previously
(24). The patterns obtained from the clinical samples were
assigned lowercase letter designations. Thus, each virus had a
restriction pattern designated with three lowercase letters, e.g., abc
or pno (24).
Nucleotide sequence analysis.
Selected isolates were
evaluated by nucleotide sequence determination. The cDNA PCR products
were purified by agarose gel electrophoresis followed by DNA extraction
(Qiagen, Chatsworth, Calif.). Sequencing reactions were carried out
with a Thermo Sequenase radiolabeled terminator cycle sequencing kit
(Amersham Life Science Inc., Cleveland, Ohio). The primers were G714
(GCCAACCATCAACACCACC; complementary to bases 714 to 722 of
the A2 G-protein mRNA sequence) (9) for group A viruses or
G718 (CCAACCCTCAAGACCAC; complementary to bases 718 to 734 of the 8/60 G-protein mRNA sequence) for group B viruses. A small
number of group A viruses with restriction pattern abc required primers
G546 and F16 for sequencing. Primer G546 (CCCTGCAGCATATGCAGC)
corresponded to bases 529 to 546 of the A2 G protein mRNA. Primer
F16 (GAGGATTGGCAACTCC) was complementary to bases 16 to 31 of a group A RS virus (strain WV12342) F protein mRNA. DNA and deduced
amino acid sequence analyses were performed with the Wisconsin Package,
version 9.1, Genetics Computer Group (Madison, Wis.) sequence analysis
programs. Phylogenetic analysis was performed by using the Clustal X
(26), PAUP (25), and MacClade (17) programs.
The percent nucleotide changes resulting in amino acid changes (see
Table 2) represents the total number of amino acid changes divided by
the total number of nucleotide changes determined by MacClade analysis
of the neighbor-joining trees (1). The amino acid and
nucleotide changes were determined by calculating the number of changes
observed in each branch of the tree as one counts from the root of the
tree to each terminal node. Then, the sum of all these changes is
calculated for each indicated region of the protein. The G-protein
amino acids included in each region that were compared (see Table 2)
were chosen from the aligned amino acid sequences as follows for the
group A and B viruses (numbers were based on the published sequences
for the G proteins of the A2 [group A] and 8/60 [group B] viruses):
region 1, 1 to 66 for group A and 6 to 83 for group B (the first 5 amino acids were omitted for group B because information was not
available for all of the isolates); region 2, 67 to 157 for group A and 84 to 152 for group B; region 3, 158 to 207 for group A and 153 to 221 for group B; region 4, 208 to 298 for group A and 222 to 292 for group
B; and region 5, 246 to 298 for group A and 249 to 292 for group B.
Nucleotide sequence accession numbers.
The nucleotide
sequences corresponding to the amino acid sequences, presented in Fig.
1, of the viruses (the designations presented here differ from those in
Fig. 1 by the addition of a prefix indicating the location [AL,
Alabama] and month and year of isolation) were submitted to GenBank
and given the indicated accession nos.: AL-12-93-179381, AF086868;
AL-12-93-179522, AF086869; AL-1-94-180081, AF086870; AL-1-94-180893,
AF086871; AL-1-94-181691, AF086872; AL-2-94-182473, AF086873;
AL-2-94-182701, AF086874; AL-2-94-183221, AF086875; AL-3-94-184002,
AF086876; AL-3-94-184431, AF086877; AL-4-94-185413, AF086878;
AL-12-94-193563, AF086879; AL-12-94-193651, AF086880; AL-12-94-194522,
AF086881; AL-11-94-194581, AF086882; AL-1-95-195462, AF086883;
AL-2-95-195563, AF086884; AL-2-95-195901, AF086885; AL-3-95-196775,
AF086886; AL-4-95-198921, AF086887; AL-10-95-203721, AF086888;
AL-11-95-204664, AF086889; AL-11-95-204682, AF086890; AL-12-95-205342,
AF086891; AL-12-95-205464, AF086892; AL-12-95-205865, AF086893;
AL-1-96-206145, AF086894; AL-1-96-206344, AF086895; AL-1-96-206846,
AF086896; AL-1-96-207347, AF086897; AL-2-96-207385, AF086898; and AL-11-93-177771, AF086899.
 |
RESULTS |
PCR analysis of intergroup RS virus variation and restriction
fragment analysis of within-group variation.
RS viruses isolated
over three annual epidemic periods (1993-1994, 1994-1995, and
1995-1996) at a children's hospital in the United States were
analyzed. The viruses were characterized as to group (group A or B) by
a PCR-based assay. Genetic variability within the groups was initially
assessed by restriction fragment analysis of the PCR products of 174 isolates (24). Some isolates (n = 79) were
also analyzed by nucleotide sequence determination of a region of the
glycoprotein-G gene (23).
Group A viruses were predominant during the first two epidemic periods,
whereas the group B viruses dominated during the last period (Table
1). Restriction fragment analysis of the
group A virus PCR products revealed additional genetic variability
within the group, with four to seven restriction patterns observed
during each period. Fewer group B viruses were available from the first two epidemic periods, and only one restriction pattern was observed; among the isolates from the last period, when more viruses were available, three group B restriction patterns were found. For the group
A viruses the predominant restriction pattern was different among
viruses from each of the three periods. Among the group B viruses the
single pattern seen during the first period was also the dominant
pattern during the third period.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Categorization of the group A and B RS viruses by their
restriction patterns and distributions over 3 epidemic years
|
|
Nucleotide sequence analysis.
The restriction fragment
analysis revealed that there was within-group genetic variability. To
more accurately define the extent of genetic variability within the
individual groups, nucleotide sequences were determined for part of the
G-protein genes for selected isolates. At least one virus from each
restriction pattern group from each period was analyzed, and for
restriction pattern groups with multiple isolates, additional viruses
were tested (Table 1). The region for which sequences were determined
is one of two variable regions of the protein and is C terminal to the
central conserved region of the G protein. The nucleotides determined
corresponded to bases 750 to 918 in the prototype group A virus (A2
strain) mRNA for the group A viruses (28). For the group B
viruses the nucleotides determined corresponded to bases 760 to 921 in
the prototype group B virus (8/60 strain) mRNA (22). Within
each restriction pattern group for which more than one isolate was
analyzed, nucleotide sequence variability was noted for all except one
group. All 18 group A RS viruses with restriction pattern bba had
identical nucleotide sequences over the three epidemic periods.
Amino acid sequence analysis.
For each restriction pattern
group, one example of each unique amino acid sequence is shown (Fig.
1). Deduced amino acid sequences for
group A RS virus were 52 or 53 residues, which would result in
G-protein lengths of 297 or 298 amino acids (assuming normal reading
frame usage for the full protein). All but two of the group A amino
acid sequences included recognition signals for potential N-linked
sugar addition at either residue 250 or residue 251, some of the
isolates had an additional potential N-linked sugar site at residue
273, and all of the isolates except for the prototype A2 strain had a
potential N-linked sugar site at residue 294. All of the group B
isolates, but not the prototype 8/60 strain, had potential N-linked
sugar sites at residues 276 and 290. Deduced amino acid sequences for
group B RS virus were from 43 to 46 residues, which would result in
G-protein lengths of from 291 to 294 amino acids (assuming normal
reading frame usage for the full protein).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
Alignment of the deduced amino acid sequences of G
proteins of the group A (A) and group B (B) isolates from a children's
hospital. The sequences from amino acids 246 (group A) or 249 (group B)
to the end of the G protein are shown in comparison with the sequence
of prototype isolate A2 (A) or 8/60 (B). Differences in the sequences
of the isolates from clinical samples in comparison to the sequences of
the prototype isolates are shown. The name of each virus isolated in
the Children's Hospital of Alabama begins each line, and restriction
patterns are shown at the end of the sequence. Symbols: , potential
N-linked glycosylation sites in any of the sequences; *, termination
codons. The residues are indicated by numbers at the ends of the dashed
lines at the bottom; dots above the sequences indicate 10-residue
increments, with residues 260 and 280 being shown.
|
|
The extent of amino acid variation was assessed by pairwise comparisons
within each antigenic group. These results were summarized graphically
(Fig. 2). Among the group A isolates from
the children's hospital, the greatest extent of amino acid differences
was 38%. Compared to the sequence of the prototype A2 isolate
(isolated in Australia in 1962), the sequences of the group A isolates
from the children's hospital differed by as much as 31%. The
sequences of the group A isolates from the children's hospital were
also compared to published sequences of the group A virus G protein available through GenBank (for a list of the viral sequences which were
compared, see Fig. 3); differences of up to 40.4% were observed for
the region examined here.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Pairwise distances among group A (A) and group B (B) RS
virus G proteins. All possible pairwise comparisons were made among
amino acid sequences from isolates at the children's hospital and
published human RS virus G-protein sequences available through GenBank
for the region of the G protein analyzed in this report. See Fig. 3 for
a list of the published sequences which were used here. The distances
represent the number of substitutions/100 amino acids (aa) for each
pairwise comparison. No correction was used for multiple substitutions
at single sites. The figure plots the number of pairwise sequence
comparisons that have distance measurements within each indicated
range. Sequence distances for group A and group B viruses are shown
separately by using different scales for the number of sequence
comparisons.
|
|
Among the group B RS virus isolates from the children's hospital, the
greatest extent of amino acid differences was 14%. Compared to the
sequence of the prototype 8/60 group B isolate (isolated in Sweden in
1960), the sequences of the group B isolates from the children's
hospital differed by up to 25%, and compared to the sequence of the
prototype 18537 group B isolate (isolated in Washington, D.C., in
1962), the sequences of the group B isolates from the children's
hospital differed by up to 27%. The sequences of the group B isolates
from the children's hospital were also compared to published sequences
of the G protein from viruses isolated from 1977 to 1989 (for a list of
the viral sequences which were compared, see Fig. 3); the differences
were less than those seen for the 8/60 and 18537 viruses.
Phylogenetic analysis.
Phylogenetic comparisons of the
C-terminal variable region among the isolates described here and the
published sequences for RS virus G-protein genes available through
GenBank were performed (Fig. 3). When
group A and group B viral sequences were analyzed together, two
lineages separating the group A and B viruses were evident. To
facilitate comparisons, the group A and group B sequences were analyzed
separately. Among the group A viruses, two broad lineages and multiple
sublineages were seen (Fig. 3A). Viruses from Alabama appeared in both
group A lineages. Isolates from Birmingham, United Kingdom; Montevideo,
Uruguay; and Madrid, Spain, also appeared in both lineages (5, 12,
23).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Group A (A) and B (B) RS virus G-protein phylogenetic
relationships. Partial G-protein sequences from RS viruses isolated at
the Children's Hospital of Alabama were compared to published
G-protein sequences available through GenBank. Viruses are identified
by the geographic location (from the United States, al, Alabama; wv,
West Virginia [23]; dc, District of Columbia
[16], ma, Massachusetts [23]; md,
Maryland [16], and nm, New Mexico
[23]; from the United Kingdom, uk
[5]; from Spain, mad, Madrid; from Uruguay, mon,
Montevideo [12]; from Sweden, swed
[22]; and from Australia, aus [28]),
year or month and year of isolation, and, for isolates from the United
States and the United Kingdom a number designation. For isolates from
Alabama a three-letter designation that describes the restriction
pattern observed after restriction endonuclease digestion of the PCR
DNA products follows the designations described above. A single
sequence was used for each unique nucleotide sequence within each
restriction fragment pattern among the isolates described here (Table
1). The nucleotide sequence alignments of either group A or group B
sequences were used to create the neighbor-joining trees displayed in
the figure. The scales represent either 0.02 (group A) or 0.01 (group
B) substitutions per base per indicated horizontal distance. The
numbers present at some of the internal nodes of the trees represent
the number of bootstrap replicates of 1,000 that display the indicated
sequence groupings. Only significant bootstrap replicate numbers with
values of greater than 800 are shown.
|
|
Among the group B viruses, multiple lineages were also evident (Fig.
3B). The number of previously described group B viruses available for
comparison was more limited than the number of group A viruses
available for comparison. The three oldest isolates, 8/60, 18537, and
9320, were on a branch separate from the more recent isolates.
Selection for change.
Earlier studies have shown that there
are conserved and variable regions of the G protein. In addition, a
high proportion of the nucleotide changes (~50%, as calculated for
the entire protein) have been observed to result in amino acid changes,
suggesting that there may be a selective pressure for change (5,
15, 16, 23). The percent nucleotide changes which resulted in amino acid changes was calculated (Table
2). Among the group A viruses the
proportions of nucleotide changes resulting in amino acid changes were
13% for the conserved central region and 61% for the second variable
region analyzed here. The group B viruses had similar results. If
nucleotide changes are occurring randomly, 24% of the encoded amino
acids will change (1). Thus, for both the group A and group
B viruses, these results were compatible with there being a positive
selection for change in the variable regions of the G protein and
conservation of sequences in the central region. These data were in
agreement with those from earlier analyses of group A RS virus
G-protein variability (12).
 |
DISCUSSION |
Genetic variability was analyzed for RS viruses isolated at a
children's hospital in the United States over a 3-year period. Viruses
were characterized as to antigenic group (group A or B), and
within-group variability was assessed by restriction fragment analysis
and nucleotide sequence determination.
Although viruses of both antigenic groups were present each year, the
group A viruses were dominant for 2 years, followed by a year in which
group B isolates predominated. Similar variability has been described
in other studies, and overall, the group A viruses are more frequently
identified than the group B viruses (2, 7, 14, 20). In a
study performed in Finland, alternating group A and B virus dominance
has been observed (27). Infections with a virus of one
antigenic group increase the likelihood that if a reinfection occurs it
will be with a virus of the opposite antigenic group (18,
27).
In addition to the differences in the viral groups isolated each year,
restriction pattern analysis showed that the group A viruses which were
dominant during the first two epidemic periods were genetically
distinct from year to year. Nucleotide and deduced amino acid sequences
were determined for isolates from each restriction pattern group.
Additional genetic variability was found among isolates within most but
not all restriction fragment groups. A previous study suggested that
there was less variability among the group B viruses than among the
group A viruses (23). The data presented here confirm this
observation for isolates from a period spanning three epidemics at a
single location (Fig. 2). However, the group B viruses have the
potential for additional variability, as evidenced by comparisons to
the prototype strain. Whether the analysis of additional group B
isolates would reveal even greater differences remains to be
determined. The extent to which the individual viruses vary locally and
over time could influence the pattern of reinfections with different
viral strains. The group A viruses may vary more extensively than the
group B viruses. We postulate that this might play a role in the
predominance of group A viruses over group B viruses in many studies of
RS virus epidemiology.
Human antibody responses to linear epitopes of the variable region of
the group A RS virus G protein analyzed here have been assessed. The
reactivity of human antibodies with synthetic peptides varied with the
infecting RS virus group. In addition, all of the defined linear
epitopes included potential N-linked glycosylation sites in some of the
RS virus isolates. It was suggested that the modulation of
glycosylation sites might be a mechanism for evasion of the host immune
response by RS virus (4). Interestingly, for the viruses
studied here, variation was noted among potential N-linked
glycosylation sites described in the study mentioned above
(4) (Fig. 1). The variable reactivities of human antibodies against peptides from this region of the G protein suggest the potential importance of antigenic changes in this region.
Phylogenetic analysis showed that the group A and group B viruses were
placed in multiple lineages. Most of the major phylogenetic branches
included viruses which were isolated in this study, reflecting the
great diversity of RS viruses which may be present in a community over
a period of 3 years. However, among the group A viruses it was also
clear that viruses isolated at different times and from different
places could be very similar to the viruses isolated at our children's
hospital. Thus, viruses from the United Kingdom, Spain, and Uruguay
which were isolated several years before the viruses studied here were
isolated could be grouped phylogenetically with these viruses. The
observation that very similar viruses are isolated at different times
and from geographically distant sites demonstrates that the virus is
capable of worldwide spread (9, 12).
The study presented here was designed to assess variability in a
detailed manner over a limited period of time. Thus, the study was not
intended to address the issue of change over time. For the group A RS
viruses, there appears to be an accumulation of change over time
(9). The oldest group B isolates, 8/60, 18537, and 9320 (isolated in 1960, 1962, and 1977, respectively), were in a separate
lineage from the more recent group B isolates. This observation is also
compatible with the accumulation of changes among the group B RS
viruses over time. However, until a greater number of more
chronologically and geographically disperse isolates have been
examined, this issue remains speculative for the group B RS viruses.
These results confirm the variability among group A RS virus isolates
which has been demonstrated previously (9, 12). The data
also show that variability occurs among group B RS viruses, although to
a lesser extent than among the group A viruses. Among both the group A
and group B RS viruses, a high percentage (>60%) of nucleotide
changes resulted in amino acid coding changes in the variable region of
the G protein studied here. These data indicate that the group B RS
virus G proteins, while less variable in this study, are no more likely
to have synonymous mutations than are the group A RS virus G proteins.
The high percentage of nucleotide changes which resulted in amino acid
coding changes suggested that there may be a selective advantage to
G-protein changes (1, 5, 23). One possible advantage would
be that such changes result in an escape from the host immune response. This might contribute to the ability of RS viruses to establish infections throughout life. Longitudinal community-based studies of RS
virus variability will be necessary to define precisely the
contribution of antigenic variation to RS virus reinfections.
 |
ACKNOWLEDGMENTS |
Support for this study was received from Public Health Service
grant AI33425 (to W.M.S.). Support for nucleotide sequence analysis was
provided by the Center for AIDS Research (PO AI27767) and the X-Ray
Crystallography Core Facility (CA13148) at the University of Alabama.
Support for the synthesis of oligonucleotides was provided though NCI
grant CA13148 to the University of Alabama Comprehensive Cancer Center.
We thank Kimberly Grantham Edwards and Margaret Amsler for technical
assistance, Dana Pinson for secretarial support, and the members of the
Diagnostic Virology Laboratory for assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: UAB Department
of Pediatrics, 1600 7th Ave. South, Suite 752, Birmingham, AL 35233. Phone: (205) 934-3092. Fax: (205) 975-6549. E-mail:
Pedp019{at}uabdpo.dpo.uab.edu.
Present address: Roswell Health Department, Roswell, NM 88202.
 |
REFERENCES |
| 1.
|
Air, G. M.,
A. J. Gibbs,
W. Laver, and R. G. Webster.
1990.
Evolutionary changes in influenza B are not primarily governed by antibody selection.
Proc. Natl. Acad. Sci. USA
87:3884-3888[Abstract/Free Full Text].
|
| 2.
|
Anderson, L. J.,
R. M. Hendry,
L. T. Pierik,
C. Tsou, and K. McIntosh.
1991.
Multicenter study of strains of respiratory syncytial virus.
J. Infect. Dis.
163:687-692[Medline].
|
| 3.
|
Anderson, L. J.,
J. C. Hierholzer,
C. Tsou,
R. M. Hendry,
B. F. Fernie,
Y. Stone, and K. McIntosh.
1985.
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.
J. Infect. Dis.
151:626-633[Medline].
|
| 4.
|
Cane, P. A.
1997.
Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus.
J. Med. Virol.
51:297-304[Medline].
|
| 5.
|
Cane, P. A.,
D. A. Matthews, and C. R. Pringle.
1991.
Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses.
J. Gen. Virol.
72:2091-2096[Abstract/Free Full Text].
|
| 6.
|
Cane, P. A.,
D. A. Matthews, and C. R. Pringle.
1992.
Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide.
Virus Res.
25:15-22[Medline].
|
| 7.
|
Cane, P. A.,
D. A. Matthews, and C. R. Pringle.
1994.
Analysis of respiratory syncytial virus strain variation in successive epidemics in one city.
J. Clin. Microbiol.
32:1-4[Abstract/Free Full Text].
|
| 8.
|
Cane, P. A., and C. R. Pringle.
1991.
Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene).
J. Gen. Virol.
72:349-357[Abstract/Free Full Text].
|
| 9.
|
Cane, P. A., and C. R. Pringle.
1995.
Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein.
J. Virol.
69:2918-2925[Abstract].
|
| 10.
|
Collins, P. L.,
K. McIntosh, and R. M. Chanock.
1996.
Respiratory syncytial virus, p. 1313-1351.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
|
| 11.
|
Cristina, J.,
J. A. Lopez,
C. Albo,
B. Garcia-Barreno,
J. Garcia,
J. A. Melero, and A. Portela.
1990.
Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity.
Virology
174:126-134[Medline].
|
| 12.
|
Garcia, O.,
M. Martin,
J. Dopazo,
J. Arbiza,
S. Frabasile,
J. Russi,
M. Hortal,
P. Perez-Brena,
I. Martinez,
B. Garcia-Barreno, and J. A. Melero.
1994.
Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.
J. Virol.
68:5448-5459[Abstract/Free Full Text].
|
| 13.
|
Hall, C. B.,
E. E. Walsh,
K. C. Schnabel,
C. E. Long,
K. M. McConnochie,
S. W. Hildreth, and L. J. Anderson.
1990.
Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children.
J. Infect. Dis.
162:1283-1290[Medline].
|
| 14.
|
Hendry, R. M.,
L. T. Pierik, and K. McIntosh.
1989.
Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987.
J. Infect. Dis.
160:185-190[Medline].
|
| 15.
|
Johnson, P. R., and P. L. Collins.
1989.
The 1B (NS2), 1C (NS1) and N proteins of human respiratory syncytial virus (RSV) of antigenic subgroups A and B: sequence conservation and divergence within RSV genomic RNA.
J. Gen. Virol.
70:1539-1547[Abstract/Free Full Text].
|
| 16.
|
Johnson, P. R.,
M. K. Spriggs,
R. A. Olmsted, and P. L. Collins.
1987.
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.
Proc. Natl. Acad. Sci. USA
84:5625-5629[Abstract/Free Full Text].
|
| 17.
|
Maddison, W. P., and D. R. Maddison.
1992.
MacClade. Analysis of phylogeny and character evoluation, 33.
Sinauer Associates, Inc., Sunderland, Mass.
|
| 18.
|
Mufson, M. A.,
R. B. Belshe,
C. Orvell, and E. Norrby.
1987.
Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.
J. Clin. Microbiol.
25:1536-1539.
|
| 19.
|
Mufson, M. A.,
C. Orvell,
B. Rafnar, and E. Norrby.
1985.
Two distinct subtypes of human respiratory syncytial virus.
J. Gen. Virol.
66:2111-2124[Abstract/Free Full Text].
|
| 20.
|
Storch, G. A., and C. S. Park.
1987.
Monoclonal antibodies demonstrate heterogeneity in the G glycoprotein of prototype strains and clinical isolates of respiratory syncytial virus.
J. Med. Virol.
22:345-356[Medline].
|
| 21.
|
Storch, G. A.,
C. S. Park, and D. E. Dohner.
1989.
RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology.
J. Clin. Invest.
83:1894-1902.
|
| 22.
|
Sullender, W. M.,
K. Anderson, and G. W. Wertz.
1990.
The respiratory syncytial virus subgroup B attachment glycoprotein: analysis of sequence, expression from a recombinant vector, and evaluation as an immunogen against homologous and heterologous subgroup virus challenge.
Virology
178:195-203[Medline].
|
| 23.
|
Sullender, W. M.,
L. J. Anderson,
M. A. Mufson, and G. W. Wertz.
1991.
Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses.
J. Virol.
65:5425-5434[Abstract/Free Full Text].
|
| 24.
|
Sullender, W. M.,
L. Sun, and L. J. Anderson.
1993.
Analysis of respiratory syncytial virus genetic variability with amplified cDNAs.
J. Clin. Microbiol.
31:1224-1231[Abstract/Free Full Text].
|
| 25.
|
Swofford, D. L.
1993.
PAUP: phylogenetic analysis using parsimony, 3.1.
Illinois Natural History Survey, Champaign.
|
| 26.
|
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680[Abstract/Free Full Text].
|
| 27.
|
Waris, M.
1991.
Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B.
J. Infect. Dis.
163:464-469[Medline].
|
| 28.
|
Wertz, G. W.,
P. L. Collins,
Y. Huang,
C. Gruber,
S. Levine, and L. A. Ball.
1985.
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein.
Proc. Natl. Acad. Sci. USA
82:4075-4079[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, December 1998, p. 3552-3557, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zlateva, K. T., Vijgen, L., Dekeersmaeker, N., Naranjo, C., Van Ranst, M.
(2007). Subgroup Prevalence and Genotype Circulation Patterns of Human Respiratory Syncytial Virus in Belgium during Ten Successive Epidemic Seasons. J. Clin. Microbiol.
45: 3022-3030
[Abstract]
[Full Text]
-
Parveen, S., Sullender, W. M., Fowler, K., Lefkowitz, E. J., Kapoor, S. K., Broor, S.
(2006). Genetic variability in the g protein gene of group a and B respiratory syncytial viruses from India.. J. Clin. Microbiol.
44: 3055-3064
[Abstract]
[Full Text]
-
Trento, A., Viegas, M., Galiano, M., Videla, C., Carballal, G., Mistchenko, A. S., Melero, J. A.
(2006). Natural History of Human Respiratory Syncytial Virus Inferred from Phylogenetic Analysis of the Attachment (G) Glycoprotein with a 60-Nucleotide Duplication. J. Virol.
80: 975-984
[Abstract]
[Full Text]
-
Zlateva, K. T., Lemey, P., Moes, E., Vandamme, A.-M., Van Ranst, M.
(2005). Genetic Variability and Molecular Evolution of the Human Respiratory Syncytial Virus Subgroup B Attachment G Protein. J. Virol.
79: 9157-9167
[Abstract]
[Full Text]
-
Galiano, M. C., Palomo, C., Videla, C. M., Arbiza, J., Melero, J. A., Carballal, G.
(2005). Genetic and Antigenic Variability of Human Respiratory Syncytial Virus (Groups A and B) Isolated over Seven Consecutive Seasons in Argentina (1995 to 2001). J. Clin. Microbiol.
43: 2266-2273
[Abstract]
[Full Text]
-
Kuroiwa, Y., Nagai, K., Okita, L., Tsutsumi, H.
(2004). Genetic Variability and Molecular Epidemiology of Respiratory Syncytial Virus Subgroup A Strains in Japan Determined by Heteroduplex Mobility Assay. J. Clin. Microbiol.
42: 2048-2053
[Abstract]
[Full Text]
-
Bastien, N., Ward, D., Van Caeseele, P., Brandt, K., Lee, S. H. S., McNabb, G., Klisko, B., Chan, E., Li, Y.
(2003). Human Metapneumovirus Infection in the Canadian Population. J. Clin. Microbiol.
41: 4642-4646
[Abstract]
[Full Text]
-
Venter, M., Madhi, S. A., Tiemessen, C. T., Schoub, B. D.
(2001). Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J. Gen. Virol.
82: 2117-2124
[Abstract]
[Full Text]
-
Taylor, G. S., Vipond, I. B., Caul, E. O.
(2001). Molecular Epidemiology of Outbreak of Respiratory Syncytial Virus within Bone Marrow Transplantation Unit. J. Clin. Microbiol.
39: 801-803
[Abstract]
[Full Text]
-
Roca, A., Loscertales, M.-P., Quintó, L., Pérez-Breña, P., Vaz, N., Alonso, P.-L., Saiz, J.-C.
(2001). Genetic variability among group A and B respiratory syncytial viruses in Mozambique: identification of a new cluster of group B isolates. J. Gen. Virol.
82: 103-111
[Abstract]
[Full Text]
-
Sullender, W. M.
(2000). Respiratory Syncytial Virus Genetic and Antigenic Diversity. Clin. Microbiol. Rev.
13: 1-15
[Abstract]
[Full Text]